Clinical Investigation of the SelectSecure Pacing Lead
Primary Purpose
Bradycardia
Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Pacing Lead
Sponsored by
About this trial
This is an interventional treatment trial for Bradycardia focused on measuring Bradycardia
Eligibility Criteria
Inclusion Criteria: Subjects who are in need of a pacemaker that paces in both the right atrium and ventricle. Exclusion Criteria: Subjects who are in need of an implantable cardioverter defibrillator (ICD). Subjects who have a mechanical or diseased tricuspid valve (a structure in the heart, located between the right atrium and right ventricle, which allows blood to flow from the atrium to the ventricle). Steroid contraindication
Sites / Locations
Outcomes
Primary Outcome Measures
3-month safety (complications and all lead-related adverse events) and efficacy ( pacing and sensing) objectives
Secondary Outcome Measures
Lead and catheter handling characteristics, and lead impedance
Full Information
NCT ID
NCT00266682
First Posted
December 16, 2005
Last Updated
October 11, 2006
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
1. Study Identification
Unique Protocol Identification Number
NCT00266682
Brief Title
Clinical Investigation of the SelectSecure Pacing Lead
Official Title
Clinical Investigation of the SelectSecure Pacing Lead
Study Type
Interventional
2. Study Status
Record Verification Date
October 2006
Overall Recruitment Status
Completed
Study Start Date
August 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2005 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Medtronic Cardiac Rhythm and Heart Failure
4. Oversight
5. Study Description
Brief Summary
People who have a slow heart beat, or whose heart does not beat on its own, may be in need of an electronic device called a pacemaker. A pacemaker is implanted surgically just under the skin in the upper chest area. This device helps the heart beat at a regular rhythm by sending electrical signals (pacing) directly to the heart tissue through flexible wires called leads. The purpose of this study is to demonstrate that the SelectSecure (Model 3830) lead is safe and effective for both sensing the heart's natural rhythm and pacing the heart when it does not beat on its own. This lead will be studied in both the right atrium and right ventricle. A previously market approved Medtronic lead model will serve as a comparison to prove the safety and effectiveness of the SelectSecure Model.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bradycardia
Keywords
Bradycardia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
365 (false)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
Pacing Lead
Primary Outcome Measure Information:
Title
3-month safety (complications and all lead-related adverse events) and efficacy ( pacing and sensing) objectives
Secondary Outcome Measure Information:
Title
Lead and catheter handling characteristics, and lead impedance
10. Eligibility
Sex
All
Minimum Age & Unit of Time
0 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects who are in need of a pacemaker that paces in both the right atrium and ventricle.
Exclusion Criteria:
Subjects who are in need of an implantable cardioverter defibrillator (ICD).
Subjects who have a mechanical or diseased tricuspid valve (a structure in the heart, located between the right atrium and right ventricle, which allows blood to flow from the atrium to the ventricle).
Steroid contraindication
Facility Information:
City
Anchorage
State/Province
Alaska
Country
United States
City
Peoria
State/Province
Arizona
Country
United States
City
Long Beach
State/Province
California
Country
United States
City
Santa Rosa
State/Province
California
Country
United States
City
Fort Lauderdale
State/Province
Florida
Country
United States
City
Evanston
State/Province
Illinois
Country
United States
City
Indianapolis
State/Province
Indiana
Country
United States
City
Des Moines
State/Province
Iowa
Country
United States
City
Iowa City
State/Province
Iowa
Country
United States
City
Kansas City
State/Province
Kansas
Country
United States
City
Boston
State/Province
Massachusetts
Country
United States
City
Detroit
State/Province
Michigan
Country
United States
City
Robbinsdale
State/Province
Minnesota
Country
United States
City
St. Paul
State/Province
Minnesota
Country
United States
City
Kansas City
State/Province
Missouri
Country
United States
City
Springfield
State/Province
Missouri
Country
United States
City
Livingston
State/Province
New Jersey
Country
United States
City
Winston-Salem
State/Province
North Carolina
Country
United States
City
Cincinnati
State/Province
Ohio
Country
United States
City
Lancaster
State/Province
Pennsylvania
Country
United States
City
Sayre
State/Province
Pennsylvania
Country
United States
City
Germantown
State/Province
Tennessee
Country
United States
City
Nashville
State/Province
Tennessee
Country
United States
City
Austin
State/Province
Texas
Country
United States
City
Temple
State/Province
Texas
Country
United States
City
Richmond
State/Province
Virginia
Country
United States
City
Melbourne
Country
Australia
City
Kingston
Country
Canada
City
London
Country
Canada
City
Ottawa
Country
Canada
City
Sainte-Foy
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Clinical Investigation of the SelectSecure Pacing Lead
We'll reach out to this number within 24 hrs